重性精神疾病中的炎症与认知:协变模式与亚组
该研究在精神分裂症(SZ)、双相障碍(BD)和健康对照(HC)大样本中,采用典型相关分析(CCA)探究认知域与炎症/免疫标志物的协变模式。发现言语学习和精神运动处理速度差与白介素-18系统细胞因子及β防御素2升高相关,反映先天免疫激活增强,且在重性精神疾病(SMI)中更明显。基于协变模式的聚类识别出高认知-低免疫失调亚组(以HC为主)和低认知-高免疫失调亚组(以SMI为主),两组在IQ、教育年限、年龄、CRP、BMI、功能水平、症状及抗精神病药定义日剂量(DDD)上存在差异。
要点
- 言语学习和精神运动处理速度差与白介素-18系统细胞因子及β防御素2升高相关。
- 先天免疫激活增强的协变模式在SMI中比HC更明显。
- 聚类识别出高认知-低免疫失调和低认知-高免疫失调两个亚组,后者以SMI为主。
核心结论
- 部分重性精神疾病患者存在认知损害与先天免疫失调的关联。
研究设计与样本
- 在SZ=343、BD=289、HC=770的队列中,采用典型相关分析(CCA)探究认知域与炎症/免疫标志物的协变模式,并对协变模式进行层次聚类。
主要发现
- 言语学习和精神运动处理速度差与白介素-18系统细胞因子及β防御素2水平高相关,反映先天免疫激活增强。
- 该协变模式在SMI中比HC更明显。
- 聚类得到高认知-低免疫失调亚组(24% SZ、45% BD、74% HC)和低认知-高免疫失调亚组(76% SZ、55% BD、26% HC)。
- 两亚组在IQ、教育年限、年龄、CRP、BMI(所有组)、功能水平、症状及抗精神病药DDD(SMI队列)上存在差异。
临床怎么用
- 对SMI患者评估认知功能时,可关注言语学习和精神运动处理速度,并考虑先天免疫激活标志物的潜在关联。
- 识别低认知-高免疫失调亚组可能有助于个体化评估,但需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A potential relationship between dysregulation of immune/inflammatory pathways and cognitive impairment has been suggested in severe mental illnesses (SMI), such as schizophrenia (SZ) and bipolar (BD) spectrum disorders. However, multivariate relationships between peripheral inflammatory/immune-related markers and cognitive domains are unclear, and many studies do not account for inter-individual variance in both cognitive functioning and inflammatory/immune status. This study aimed to investigate covariance patterns between inflammatory/immune-related markers and cognitive domains and further elucidate heterogeneity in a large SMI and healthy control (HC) cohort (SZ = 343, BD = 289, HC = 770). We applied canonical correlation analysis (CCA) to identify modes of maximum covariation between a comprehensive selection of cognitive domains and inflammatory/immune markers. We found that poor verbal learning and psychomotor processing speed was associated with higher levels of interleukin-18 system cytokines and beta defensin 2, reflecting enhanced activation of innate immunity, a pattern augmented in SMI compared to HC. Applying hierarchical clustering on covariance patterns identified by the CCA revealed a high cognition-low immune dysregulation subgroup with predominantly HC (24% SZ, 45% BD, 74% HC) and a low cognition-high immune dysregulation subgroup predominantly consisting of SMI patients (76% SZ, 55% BD, 26% HC). These subgroups differed in IQ, years of education, age, CRP, BMI (all groups), level of functioning, symptoms and defined daily dose (DDD) of antipsychotics (SMI cohort). Our findings suggest a link between cognitive impairment and innate immune dysregulation in a subset of individuals with severe mental illness.
引用
- Sæther LS, Ueland T, Haatveit B, et al. Inflammation and cognition in severe mental illness: patterns of covariation and subgroups. Mol Psychiatry. 2022. PMID: 36577840. doi:10.1038/s41380-022-01924-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。